Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06293430 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry on Luma Vision's VERAFEYE System (ENLIgHT)

Study acronym: ENLIgHT
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Oct 15, 2027 → Dec 15, 2027
See other at-risk trials from LUMA Vision Ltd.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Feb 15, 2027 to May 15, 2027
    • Primary and study completion pushed from Oct 15, 2027 to Dec 15, 2027
    • Eligibility criteria expanded, about 9 words
  2. Start date: Jan 15, 2027 to Feb 15, 2027
    • Primary and study completion pushed from Sep 15, 2027 to Oct 15, 2027
    v22
  3. Start date: Dec 15, 2026 to Jan 15, 2027
    • Primary and study completion pushed from Aug 15, 2027 to Sep 15, 2027
    v21
  4. Start date: Nov 15, 2026 to Dec 15, 2026
    • Primary and study completion pushed from Jul 15, 2027 to Aug 15, 2027
    v20
  5. Start date: Oct 15, 2026 to Nov 15, 2026
    • Primary and study completion pushed from Jun 15, 2027 to Jul 15, 2027
    v19
Show 17 earlier versionsHide 17 earlier versions
  1. Re-verified, no change to tracked fieldsv18
  2. Start date: Jun 15, 2026 to Oct 15, 2026
    • Primary and study completion dates: Mar 15, 2027 to Jun 15, 2027
    v17
  3. Primary and study completion dates: Aug 15, 2026 to Mar 15, 2027
    • Start date: Dec 15, 2025 to Jun 15, 2026
    v16
  4. Start date: Nov 15, 2025 to Dec 15, 2025
    • Primary and study completion dates: Jul 15, 2026 to Aug 15, 2026
    v15
  5. Start date: Oct 15, 2025 to Nov 15, 2025
    • Primary and study completion dates: Jun 15, 2026 to Jul 15, 2026
    v14
  6. Start date: Sep 15, 2025 to Oct 15, 2025
    • Primary and study completion dates: May 15, 2026 to Jun 15, 2026
    v13
  7. Start date: May 15, 2025 to Sep 15, 2025
    • Primary and study completion dates: Dec 15, 2025 to May 15, 2026
    v12
  8. Start date: Apr 15, 2025 to May 15, 2025
    • Primary and study completion dates: Nov 15, 2025 to Dec 15, 2025
    v11
  9. Start date: Mar 15, 2025 to Apr 15, 2025
    • Primary and study completion dates: Oct 15, 2025 to Nov 15, 2025
    v10
  10. Eligibility criteria revisedv9
  11. Primary endpoints: 2 to 1
    • Eligibility criteria shortened, about 5 words
    v8
  12. Start date: Nov 15, 2024 to Mar 15, 2025
    • Primary and study completion dates: May 15, 2025 to Oct 15, 2025
    v7
  13. Start date: Sep 15, 2024 to Nov 15, 2024
    • Primary and study completion dates: Mar 15, 2025 to May 15, 2025
    v6
  14. 3 versions Re-verified since May 7, 2024, no change to tracked fieldsv3-v5
  15. Eligibility criteria expanded, about 14 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures.
Trial Details
NCT Number NCT06293430
Lead Sponsor LUMA Vision Ltd.
Conditions
(from sponsor)		 Atrial Fibrillation, Left Atrial Appendage Closure, Atrial Arrhythmia
Related terms Atrial Fibrillation
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov